Last week, the Guardian’s curiously-titled Health and Inequalities correspondent reported that the Medicines and Healthcare products Regulatory Agency (MHRA) had issued an alert over the effects of weight-loss drugs on contraception.
The warning came in the light of 40 reports of pregnancies occurring while women were using drugs such as Ozempic, Wegovy and Mounjaro.
The MHRA noted that Mounjaro – a drug which, unlike Ozempic and Wegovy, does not include semaglutide – may similarly reduce the effectiveness of oral contraception such as the Pill. It continued: “Therefore, those taking Mounjaro who are overweight and are using an oral form of contraception are advised to also use a non-oral form of contraception.”
